Abstract
An open trial was conducted in 22 in-patients with classic or definite rheumatoid arthritis (RA) and 17 in-patients with M. Bechterew with the aim to investigate the effect of increasing concentrations of piroxicamin vivo on the platelet aggregation in such patients. In all patients therapy with piroxicam (10 mg/d) was started after with-drawing other non-steroidal antiinflammatory drugs. In 36 cases the daily dose of piroxicam was increased to 20 mg/d and in five cases to 30 mg/d based on clinical judgment. The platelet aggregation in platelet-rich plasma (PRP) caused by epinephrine, ADP (both 5 μM) and collagen (2 μg/ml) was measured at the beginning of the trial and before each dose increase. The results of the trial suggest that a significant positive correlation exists between increasing serum concentrations of piroxicam and the degree of inhibition of platelet aggregation, caused by all three platelet aggregation agonists. This action of piroxicam was most pronounced when epinephrine was used as platelet agonist.
Similar content being viewed by others
References
G. V. R. Born,Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature194, 927–929 (1962).
J. R. O'Brien,Platelet aggregation. J. Clin. Pathol.15, 446–455 (1962).
I. F. Charo, R. D. Feinman and T. C. Detweiler,Interrelations of platelet aggregation and secretion. J. Clin. Invest.60, 866–873 (1977).
D. C. McMillan,Secondary clumping effect in human citrated platelet-rich plasma produced by adenosine diphosphate and adrenalin. Nature211, 140–144 (1966).
S. Cronberg, P. Kubisz and J. Caen,Demonstration of a plasmatic cofactor different from fibrinogen necessary for platelet release by ADP and adrenaline. Thromb. Diathes. Haemorrh.24, 409–418 (1970).
J. B. Smith and A. L. Willis,Aspirin selectively inhibits prostaglandin production in human platelets. Nature231, 235–239 (1971).
J. R. O'Brien,A comparison of an effect of different anti-inflammatory drugs on platelets. J. Clin. Pathol.23, 522–525 (1970).
B. A. McIntyre and R. B. Philip,Effect of three non-steroidal anti-inflammatory agents on platelet, function and prostaglandin synthesis in vitro Thromb. Res.12, 67–77 (1977).
J. J. Kocsis, J. Hernandovic, M. J. Silver, J. B. Smith and C. Ingerman,Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins3, 141–148 (1973).
F. E. Preston, S. Whipps, C. A. Jackson, A. J. French, P. J. Wyld and C. J. Stoddard,Inhibition of prostacyclin, and platelet thromboxane A2 after low-dose aspirin. New Engl. J. Med.304, 76–79 (1981).
B. J. Gaynor and J. W. Constantine,The effect of piroxicam on platelet aggregation. Experientia35, 797–798 (1979).
M. Weintraub, K. Case, B. Kroening and H. B. Bosmann,Effects of piroxicam on platelet aggregation. Clin. Pharmacol. Ther.23, 134–135 (1978).
S. Cronberg, E. Wallmark and I. Söderberg,Effect of platelet aggregation of oral administration of 10 non-steroidal analgesics to humans. Scand. J. Haematol.33, 155–159 (1984).
F. C. Arnett, S. M. Edworthy, D. A. Bloch, et al.,The criteria for the classification of rheumatoid arthritis. Arth. Rheum.31, 315–324 (1988).
P. M. Bennet and P. H. N. Wood,Population studies of the rheumatic diseases. Exc. Med. Found., Amsterdam Int. Congr. Ser.148, 456 (1966).
H. Migulla, R. G. Alken and H. Hüller,Mikromethode zur Bestimmung der Piroxicamkonzentration im Serum. Pharmazie43, 866–867 (1988).
G. Di Minno, M. J. Silver and S. Murphy,Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood61, 1081–1085 (1983).
E. M. Huang and T. C. Detwiler,Characteristics of the synergistic actions of platelet aggregation agonists. Blood57, 685–691 (1981).
R. L. Kinlough-Rathbone, M. A. Packham, H.-J. Reimers, J.-P. Cazenave and J. F. Mustard,Mechanisms of platelet shape change, aggregation and release induced by collagen, thrombin or A23,187. J. Lab. Clin. Med.90, 707–719 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koytchev, R., Alken, R.G. & Gromnica-Ihle, E. Serum concentration of piroxicam and inhibition of platelet aggregation in patients with rheumatoid arthritis and M. Bechterew. Agents and Actions 43, 48–52 (1994). https://doi.org/10.1007/BF02005764
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02005764